Neotherix CEO Mike Raxworthy has been invited to be a member of the MedTech Skills National Workgroup. This group is made up of industry representatives covering companies of all sizes in this sector and will be responsible for the development of a programme to provide a workforce having the skills required by the MedTech industry.
Mike Raxworthy will be able to draw on his experience as CEO of a regenerative medicine start-up company as well as being able to represent the industry members of Regener8 for which he is Operations Director. Mike also has experience of senior roles in large companies (Smith & Nephew, 3M Health Care) in this industry sector.
The Workgroup has been organised by Medilink UK and ABHI in partnership with Cogent.
Initial aims of the Workgroup will be to:
- Determine and agree the strategy and delivery mechanisms for the MedTech skills initiative to go forwards into the overall Science Industry Partnership bid;
- Agree and approve the budget for the MedTech skills initiative to go forwards into the overall Science Industry Partnership bid.
The Workgroup will determine the overall strategic goals of the medical technologies element of the Science Industry Partnership Proposal which was submitted as an outline bid to Government in March. It will provide direction and leadership for the individual initiatives to be undertaken, and if the final bid is successful, the Workgroup will provide ongoing operational governance.
The inaugural meeting of the Workgroup is being held at ABHI in London on 3 July, and a decision on the outline bid is expected from the UK Commission for Employment and Skills (UKCES) later in July.
See the UKCES website for more information.